ARCHIVES

FDA Approved 88% Of Cancer Applications Since Oncology Office Opened In 2005.

This article is from The Cancer Letter archive.

Vol. 34 No. 26 | July 3, 2008

Download PDF Visit The Full Archive

Related Articles

Two Phase II Studies of Ibrutinib Deliver High Response Rates

December 27, 2013

In Brief: NCI Gets $937 Million For FY 79 As Congress Adjourns; Cancer Act Renewed For Two Years

October 20, 1978

In Brief: Goldsmith Named CEO of CancerCare

April 11, 2014

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992

Surgical Oncology Planners Develop NCPP research Approaches, Projects

May 24, 1974

“Perhaps the most troubling finding was a broad dissatisfaction with the general ethos within the intramural community.”

July 14, 1995